A comprehensive review of the protein subunit vaccines against COVID-19
Two years after severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), in
December 2019, the first infections were identified in Wuhan city of China. SARS-CoV-2 …
December 2019, the first infections were identified in Wuhan city of China. SARS-CoV-2 …
[HTML][HTML] Excessive use of disinfectants against COVID-19 posing a potential threat to living beings
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan city
of China in late December 2019 and identified as a novel coronavirus disease 2019 (COVID …
of China in late December 2019 and identified as a novel coronavirus disease 2019 (COVID …
[HTML][HTML] Allium sativum derived carbon dots as a potential theranostic agent to combat the COVID-19 crisis
Abstract Coronavirus disease 2019 (COVID-19) is one of the worst pandemics to have hit
the humanity. The manifestations are quite varied, ranging from severe lung infections to …
the humanity. The manifestations are quite varied, ranging from severe lung infections to …
Coronavirus disease (COVID-19) control between drug repurposing and vaccination: a comprehensive overview
Respiratory viruses represent a major public health concern, as they are highly mutated,
resulting in new strains emerging with high pathogenicity. Currently, the world is suffering …
resulting in new strains emerging with high pathogenicity. Currently, the world is suffering …
p‐cymene impairs SARS‐CoV‐2 and Influenza A (H1N1) viral replication: In silico predicted interaction with SARS‐CoV‐2 nucleocapsid protein and H1N1 …
A Panagiotopoulos, M Tseliou… - Pharmacology …, 2021 - Wiley Online Library
Therapeutic regimens for the COVID‐19 pandemics remain unmet. In this line, repurposing
of existing drugs against known or predicted SARS‐CoV‐2 protein actions have been …
of existing drugs against known or predicted SARS‐CoV‐2 protein actions have been …
[HTML][HTML] Potential remdesivir‐related transient bradycardia in patients with coronavirus disease 2019 (COVID‐19)
C Pallotto, LR Suardi, A Gabbuti, S Esperti… - Journal of Medical …, 2021 - ncbi.nlm.nih.gov
To the Editor, Coronavirus disease 2019 (COVID‐19) is still a global concern with elevated
morbidity and mortality. 1–3 Several drugs were evaluated, but, until now, only remdesivir …
morbidity and mortality. 1–3 Several drugs were evaluated, but, until now, only remdesivir …
A Correlation among the COVID‐19 Spread, Particulate Matters, and Angiotensin‐Converting Enzyme 2: A Review
Air pollution (AP) is one of the leading causes of health risks because it causes widespread
morbidity and mortality every year. Its impact on the environment includes acid rain and …
morbidity and mortality every year. Its impact on the environment includes acid rain and …
[HTML][HTML] Guillain-Barre syndrome: An autoimmune disorder post-COVID-19 vaccination?
Abstract SARS-CoV-2 causes Coronavirus Disease 2019 (COVID-19), an infectious
condition that can present none or one or more of these symptoms: fever, cough, headache …
condition that can present none or one or more of these symptoms: fever, cough, headache …
Biologically relevant micellar nanocarrier systems for drug encapsulation and functionalization of metallic nanoparticles
V Valdivia, R Gimeno-Ferrero, M Pernia Leal… - Nanomaterials, 2022 - mdpi.com
The preparation of new and functional nanostructures has received more attention in the
scientific community in the past decade due to their wide application versatility. Among these …
scientific community in the past decade due to their wide application versatility. Among these …
A mixture of essential oils from three Cretan Aromatic Plants (thyme, Greek sage and Cretan dittany, CAPeo) inhibits SASR-CoV-2 proliferation: in vitro evidence and …
The need for therapeutic regimens for the non-critically ill patients of the COVID-19
pandemic remains unmet. In this line, repurposing existing drugs, against known or …
pandemic remains unmet. In this line, repurposing existing drugs, against known or …